AVADEL PHARMACEUTICALS PLC Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Avadel Pharmaceuticals Plc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • Avadel Pharmaceuticals Plc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$13.8M, a 78.5% increase year-over-year.
  • Avadel Pharmaceuticals Plc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$106M, a 25.6% increase year-over-year.
  • Avadel Pharmaceuticals Plc annual Net Income (Loss) Attributable to Parent for 2023 was -$160M, a 16.6% decline from 2022.
  • Avadel Pharmaceuticals Plc annual Net Income (Loss) Attributable to Parent for 2022 was -$137M, a 77.8% decline from 2021.
  • Avadel Pharmaceuticals Plc annual Net Income (Loss) Attributable to Parent for 2021 was -$77.3M, a 1200% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$160M -$22.8M -16.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 -$137M -$60.1M -77.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 -$77.3M -$84.4M -1200% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $7.03M +$40.3M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-16
2019 -$33.2M +$62.1M +65.1% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-16
2018 -$95.3M -$164M -240% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-09
2017 $68.3M +$110M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-16
2016 -$41.3M -$83.1M -199% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-15
2015 $41.8M +$127M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-16
2014 -$85.5M -$42.5M -99.1% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-28
2013 -$42.9M -$39.7M -1230% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
2012 -$3.23M +$5.55M +63.2% Jan 1, 2012 Dec 31, 2012 20-F/A 2015-10-01
2011 -$8.77M +$201K +2.24% Jan 1, 2011 Dec 31, 2011 20-F/A 2014-04-30
2010 -$8.98M Jan 1, 2010 Dec 31, 2010 20-F 2013-04-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.